Trial
NCT02336373
Treatment of Hemoglobin SC Disease With Hydroxyurea
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Hemoglobin SC Disease
Intervention
hydroxyurea
Why stopped
low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-09